RxSight, Inc. RXST
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 121.83M | 127.58M | 127.48M | 134.48M | 142.09M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 121.83M | 127.58M | 127.48M | 134.48M | 142.09M |
| Cost of Revenue | 29.08M | 28.71M | 29.30M | 31.47M | 35.55M |
| Gross Profit | 92.75M | 98.87M | 98.18M | 103.01M | 106.53M |
| SG&A Expenses | 117.38M | 117.32M | 115.88M | 112.66M | 113.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 183.28M | 182.70M | 182.83M | 182.67M | 187.57M |
| Operating Income | -61.45M | -55.11M | -55.35M | -48.19M | -45.48M |
| Income Before Tax | -53.23M | -46.84M | -46.59M | -38.88M | -35.66M |
| Income Tax Expenses | 127.00K | 109.00K | 53.00K | 65.00K | 72.00K |
| Earnings from Continuing Operations | -53.36 | -46.95 | -46.64 | -38.94 | -35.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -53.36M | -46.95M | -46.64M | -38.94M | -35.73M |
| EBIT | -61.45M | -55.11M | -55.35M | -48.19M | -45.48M |
| EBITDA | -57.84M | -51.58M | -52.02M | -44.93M | -42.55M |
| EPS Basic | -1.29 | -1.14 | -1.14 | -0.95 | -0.88 |
| Normalized Basic EPS | -0.80 | -0.71 | -0.71 | -0.59 | -0.55 |
| EPS Diluted | -1.29 | -1.14 | -1.14 | -0.95 | -0.88 |
| Normalized Diluted EPS | -0.80 | -0.71 | -0.71 | -0.59 | -0.55 |
| Average Basic Shares Outstanding | 165.68M | 164.94M | 164.19M | 163.39M | 162.58M |
| Average Diluted Shares Outstanding | 165.68M | 164.94M | 164.19M | 163.39M | 162.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |